Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
1.
Article Dans Anglais | IMSEAR | ID: sea-42499

Résumé

The incidence of thrombosis during induction chemotherapy of acute childhood lymphoblastic leukemia (ALL) patients was 6 found to be in 105 (5.7%). There were 4 cerebral infarctions, 1 superior vena cava (SVC) obstruction and 1 deep vein thrombosis. Among these, 2 of them died. A prospective study was further conducted of the change in coagulation and anticoagulation factors during 6 weeks of induction chemotherapy. It was found that the activated partial thromboplastin time (aPTT) was within normal range in all cases throughout 6 weeks, while prothrombin time (PT) and thrombin time (TT) were slightly prolonged, especially during the first 3 weeks of this phase. The natural anticoagulant panels which included protein C (PC), protein S (PS) and antithrombin III (AT III) and also fibrinogen level, were lower during the first 3 weeks and reached its nadir during the second and third week. The lower level of natural anticoagulants might be an important predisposing factor for the occurrence of thrombosis in these patients.


Sujets)
Répartition par âge , Anticoagulants/administration et posologie , Protocoles de polychimiothérapie antinéoplasique/administration et posologie , Troubles de l'hémostase et de la coagulation/physiopathologie , Tests de coagulation sanguine , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Incidence , Mâle , Leucémie-lymphome lymphoblastique à précurseurs B et T/diagnostic , Induction de rémission , Études rétrospectives , Appréciation des risques , Facteurs de risque , Répartition par sexe , Thaïlande/épidémiologie , Thrombose/traitement médicamenteux
SÉLECTION CITATIONS
Détails de la recherche